Enterprise Value to EBITDA Multiple ratio Analysis of Kazia Therapeutics Ltd ADR - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Jun-23
Very Poor EV to EBITDA
-2.40
Period Ending - Jun-22
Excellent EV to EBITDA
0.083
Growth
-2994.29 %
Trailing Twelve Months EV to EBITDA
Period Ending - Jun-23
Very Poor EV to EBITDA
-0.195
EV to EBITDA Analysis of Kazia Therapeutics Ltd ADR
| EV to EBITDA Ratio of KZIA drastically fell by -2994.29 % this year. |
| EV to EBITDA Ratio with value of 9.65 was highest in Year Jun-21 in last Five Years. |
| EV to EBITDA Ratio with value of -2.40 was lowest in Year Jun-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -2.40 is lower than Average EV to EBITDA of 1.67 in last five years. |
Other EV to EBITDA Related Info of KZIA that may interest you.
Kazia Therapeutics Ltd ADR Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| KZIA | 0.26 | 0.2497 | 4.12 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Kazia Therapeutics Ltd ADR
| Period | Jun-23 | Jun-22 | Jun-21 | Jun-20 | Jun-19 | Jun-18 | Jun-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -2.40 | 0.083 | 9.65 | 0.588 | 0.415 | 0.962 | 1.63 |
| Change | -2994.29 % | -99.14 % | 1541.23 % | 41.50 % | -56.82 % | -40.93 % | -43.93 % |
FY Chart of Enterprise Value to EBITDA Multiple of Kazia Therapeutics Ltd ADR
Note : All Data Generated at the End of Trading Hours (EOD Data)